A comparison shopper, working on behalf of major employers, struggled to find prices she could trust as she scoured health insurers' websites this spring for the cost of procedures, laboratory tests, and office visits.
Read the full story: http://tinyurl.com/79v82lg
Source: ModernHealthcare.com
“It's not easy to get in a way that makes sense, in a way that is accurate,” says Amanda Goltz, a senior manager for the Pacific Business Group on Health, a healthcare buyer coalition that includes Boeing Co., General Electric Co. and Target Corp. “Nobody has the secret sauce,” says Goltz, a comparison shopper in the coalition's latest test of the marketplace.
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Dual Therapy Appears to Benefit Patients With Pulmonary Fibrosis, Pulmonary Hypertension
May 15th 2025The combination of antifibrotic therapy and pulmonary vasodilator therapy improved transplant-free survival but had no significant impact on exercise capacity in pulmonary fibrosis and pulmonary hypertension.
Read More